Oligonucleotide-mediated AASS silencing as a potential therapeutic strategy for ALDH7A1 deficiency and glutaric aciduria type I
Year: 2026
Type: article
Source: Science Translational Medicine
Authors: Reddy Sreekanth Vootukuri, Katarzyna Dyjach, Youssef Khalil, Joanna Toporowska, Sam Rowley, Charalambos Demetriou, Nicholas D. E. Greene, Kyle O’Sullivan, Barbara Plecko, Sidney M. Gospe, Alex Mackensie, Izabella A. Pena, Peter T. Clayton, Julien Baruteau, Paul Gissen, Haiyan Zhou, Philippa B. Mills
Institutions: NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, Medical University of Graz, Duke University, University of Washington, University of Ottawa, Children's Hospital of Eastern Ontario, Great Ormond Street Hospital, Great Ormond Street Hospital for Children NHS Foundation Trust
Language: English
Subfield: Clinical Biochemistry
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7236427853
